30
CARDIOVASCULAR
hamburger

LEADERSHIP BEYOND QUESTION

Abbott’s leadership in congenital occluder therapies is due to the Amplatzer product line’s 20-year history of established therapies—and due to our dedication to continual innovation. Each year 1.35 million infants are born, worldwide, with congenital heart disease.1 Abbott has a broad portfolio of products to correct structural heart defects, as well as a devoted focus on patient safety. Consequently, we concentrate on enhancing ease of use and expanding clinical safety data for our products.

PIONEER IN PFO OCCLUSION

Because the Amplatzer line pioneered the patent foramen ovale (PFO)-specific occlusion device, it’s no surprise that the Amplatzer PFO Occluder is the leading PFO closure device.2

AMPLATZER PFO OCCLUDER

Patent foramen ovale (PFO) is often a contributing factor to cryptogenic stroke. For such patients, the Amplatzer PFO Occluder can prevent recurrent strokes.

Amplatzer PFO Occluder

AMPLATZER AMULET LAA OCCLUDER

The left atrial appendage (LAA) is the cardiac site most associated with thrombus formation in patients with non-valvular atrial fibrillation. Thrombus formation can lead to an ischemic stroke. By occluding the left atrial appendage it is possible to prevent LAA thrombi for causing an ischemic stroke.

Abbott offers the Amplatzer Amulet Occluder, a transcatheter device used to occlude the LAA, of which the safety and performance is well documented and published for risk reduction of ischemic stroke in patients with non-valvular atrial fibrillation.

Amplatzer LAA Occluder

References

1. van der Linde D, Konings EEM, Slager MA, et al. Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. J Am Coll Cardiol. 2011;58:2241–2247. doi:10.1016/j.jacc.2011.08.025.
2. Data on file at Abbott.

AP2946717-WBO Rev. A

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.

True
accessibility
© 2016 Abbott. All Rights Reserved. Please read the Legal Notice for further details.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

accessibility

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.